Chest Computed Tomography (CT) Screening Study With Antibody Testing

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2011-09-30

Study Completion Date

2011-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the value of EarlyCDT-Lung test and CT scan both in lung cancer detection and potential health economic outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of the Lung Nodule Sensitivity of Stationary Chest Tomosynthesis in Patients With Known Lung Nodules

NCT02075320

Signs and Symptoms

COMPLETED NA

Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker

NCT01700257

High Risk of Developing Lung Cancer

COMPLETED NA

Radiomics for prEdiction of lunG cAncer biologY

NCT05819905

Non Small Cell Lung Cancer PET/CT PD-L1 +1 more

UNKNOWN

Computed Tomography (CT) Perfusion Imaging of Lung Cancer

NCT00905801

Carcinoma, Non Small Cell Lung

TERMINATED NA

Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer

NCT03563976

Lung Cancer

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

EarlyCDT-Lung test and CT scan both for lung cancer detection and potential economic outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Persons 50-75
* Asymptomatic for lung cancer
* Current or former (stopped smoking less than 10 years ago) cigarette smokers
* History of cigarette smoking of at least 20 pack years
* History of cigarette smoking with a family history of lung cancer which gives an individual a personal risk similar to a smoking history of 20 pk/years (i.e. 1% at 5 years).
* Mentally competent individuals to sign an informed consent.
* Healthy enough to undergo pulmonary resection or stereotactic body radiotherapy.
* A fully informed signed consent form must have been obtained.

Minimum Eligible Age

50 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes